Targeted therapy achieves excellent outcomes, reduces side effects in high-risk Hodgkin lymphoma

by rss feed | Apr 8, 2021 | News Feeds

Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma.